Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

University of Edinburgh

  1. Events
  2. Venues
  3. University of Edinburgh
Events at this venue
Today

Translation UK 2025

The 30th Translation UK meeting will highlight the latest advancements across the broad and dynamic UK mRNA translation research community. Spanning all kingdoms of life, [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top